Overview
Status
Active
Registry date
2023-07-27
Share capital
5,000.00 PLN
Registered address
ul. Hugo Kołłątaja 3/15, 20-006 Lublin, Poland
Financials
Revenue history (in k)
Filing timeliness
1 of 3 financial statements was filed late (for 2024, 304 days late).
- 202515/05/2026
- 202415/05/2026
- 202307/05/2024
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 14.16kMedianUSD 1.06mAverageUSD 22.40m
Net profit
This companyUSD -1.37kMedianUSD 37.33kAverageUSD 880.24k
Operating costs
This companyUSD 15.53kMedianUSD 922.77kAverageUSD 21.08m
Assets
This companyUSD 2.13kMedianUSD 608.93kAverageUSD 11.85m
Industry
Authorized Representatives
Krzysztof Łątka – Attorney-in-fact
Oleh Lahodniuk – Management Board Member
Oleksandr Tkachuk – President of the Management Board
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Oleh Lahodniukage 51 | 50 | $675.31 | 50% |
Oleksandr Tkachukage 56 | 50 | $675.31 | 50% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2023-08-09.
48 1600 1462 1738 0450 2000 0002
75 1600 1462 1738 0450 2000 0001
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Przedsiębiorstwo Dystrybucji Farmaceutycznej Slawexsp. z o.o. | $600,815,720.02 | slawex.com.pl | ||
| LubfarmS.A. | $123,208,945.21 | lubfarm.pl | ||
| Camedica Paweł Harasimiuksp. k. | $18,691,613.15 | camedica.pl | ||
| Medcomplexsp. z o.o. | $5,193,830.09 | medcomplex.pl | ||
| Przedsiębiorstwo Zaopatrzenia Lecznictwa Cezal Lublinsp. z o.o. | $4,277,670.93 | cezal.lublin.pl | ||
| Bio-Novumsp. z o.o. | $3,459,663.10 | bio-novum.com | ||
| Myderm Laboratoriessp. z o.o. | $177,750.48 | myderm.com.pl | ||
| GROW Pharmasp. z o.o. | $15,020.86 | growpharma.pl | ||
| PetnovellS.A. | $0.00 | petnovell.pl | ||
| Dental Łukasiksp. j. | – | dental.lublin.pl |
FAQ
The main business activity of Sabanova focuses on wholesale of pharmaceutical goods.
The company was registered in the Polish National Court Register (KRS) on July 27, 2023.
The headquarters is located at: ul. Hugo Kołłątaja 3, 20-006 Lublin.
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
The company reported a revenue of $14,156 in 2025, which is an increase of 10.9% compared to 2024.
No, the company recorded a net loss of $1,372 in 2025. For comparison, in 2024 the loss was $2,015, meaning the company reduced its loss by 32.0%.
The largest operating cost category falls under other operating costs. This category amounted to $12,651 in 2025, representing 81% of all operating expenses.
Last updated: 2026-05-15